ArticleCancers2021

Identifying High-Risk Tumors within AJCC Stage IB-III Melanomas Using a Seven-Marker Immunohistochemical Signature.

Robin Reschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.